Olatz Izaola-Jáuregui

Suggest Changes
  • Citations Per Year
Learn More
AIMS To evaluate the effects of liraglutide after 14 weeks of treatment on serum adipokines, insulin resistance index and cardiovascular risk biomarkers in overweight or obese T2DM patients unable to(More)
  • 1